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Staged dilation and stenting for long segmental tracheobronchial
stenosis caused by tuberculosis
Pei-Ming Huang, MD,a Jin-Shing Chen, MD,a Hsao-Hsun Hsu, MD,a Yih-Leong Chang, MD,b Chung-Wei Chen, MD,a
Nai-Chuan Chien, MD,a and Yung-Chie Lee, MD, PhD,a Taipei, Taiwan
Endobronchial tuberculosis is defined as tuberculosis ofthe tracheobronchial tree (TTBT) with microbiologicalevidence. The estimated prevalence of this complicationin patients with pulmonary tuberculosis is 10% to 40%,
and more than 90% of patients with endobronchial tuberculosis
have some degree of bronchial stenosis.1 TTBT, in general, is
known for its propensity for longer segmental involvement. De-
spite adequate antituberculosis therapy, tracheobronchial stenosis
may develop.2 Although several therapeutic approaches, including
antituberculous chemotherapy combined with steroids, balloon
dilation, laser photoresection, and surgical resection, have been
attempted in these patients, the results are largely unsatisfactory.1,2
Long-segment tracheobronchial stenosis (LTBS) provides a com-
plex challenge to stenting,3 but staged stenting can offer an attrac-
tive alternative to standard LTBS therapy.
We report a method of staged stenting used to periodically
dilate the stenotic area, and this method is contrary to accepted
recommendations for the insertion of single stent or double stents.
Because the site is problematic to manage and reobstruction of the
airway is likely, repeated dilation and stenting is an appealing
option.
Clinical Summary
From February 2001 through May 2002, 3 patients (ages 28, 44,
and 62 years; 2 women and 1 man) with tuberculosis had severe
airway obstruction and were treated at our institution. The diag-
nosis of LTBS was considered if chest radiograph or sputum
culture was positive for tuberculosis and bronchoscopy and com-
puted tomography (CT) revealed stenosis of the airway. Following
failure of 6 months of medical therapy to relieve stenosis, surgical
intervention was performed to relieve the compromised airway
after the sputum cultures became negative for tuberculous bacilli.
A midline tracheostomy was performed first. After 1 to 2 weeks all
patients fasted for 8 hours before airway stenting preparation. The
Bakes common bile duct dilators (Pro-Med, Instrumente GmbH,
Tuttlingen, Germany) were employed for progressive dilation un-
der a flexible guided bronchoscope through the tracheostoma;
anesthesia was continued through the oral endotracheal tube si-
multaneously (Figure 1). The stenotic lengths were as follows: (1)
1 cm in the trachea portion and 2 cm in the left main bronchus; (2)
2 cm in the trachea portion and 3 cm in the left main bronchus; and
(3) 4 cm in the left bronchus by bronchoscopic examination during
the operation. A measured length of silicone endotracheal tube or
chest tube was used to bypass the stenotic area as the connecting
conduits to the stoma portion of conventional tracheostomy tube,
which we labeled the “tracheostomy stent” (Figure 2).
Because the tracheostomy stent was easily removed and repeat-
edly inserted, the patients could receive repeated dilation by em-
ploying a temporary tracheostomy stent via tracheostoma and
flexible bronchoscopy until the stenotic lumen become larger.
Fiberoptic bronchoscopy was performed every month until there
was no subsequent change in the endobronchial lesions, and then
the dynamic Y stents (Willy Rusch AG, Kernen, Germany) were
implanted in the individual patients 1, 2, and 8 months later,
respectively. During this period, the respective numbers of re-
peated dilations were 2, 1, and 3.
In recent follow-up study, the first patient had minimal whitish
sputum, and no granulation tissue was found in the last bronchos-
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copy, 18 months after the insertion of dynamic Y stent. The
postoperative bronchial size was about 11 to 13 mm, and the
patient felt comfortable about the implantation of dynamic Y stent
and did not want the dynamic Y stent to be removed. The dynamic
Y stent of the second patient was removed 6 months after insertion,
but proximal tracheal granulation tissue and stenosis were exam-
ined 4 months after removal of dynamic Y stent. A T tube with
outer diameter of 13 mm was inserted recently. In the third patient,
the dynamic Y stent was unpredictably slipped out during the
routine examination with a flexible bronchoscopy after 2 months,
but the lumen was enlarged during follow-up bronchoscopic ex-
amination 1 month after removal.
Discussion
Tuberculous LTBS is an unusual but not rare abnormality. It is
recommended that patients with pulmonary tuberculosis and ra-
diographic evidence of volume loss undergo bronchoscopy to rule
out tuberculous LTBS. It is difficult to evaluate the degree of
bronchial stenosis in these patients by chest radiography, which
only shows secondary changes of the lung parenchyma and en-
larged lymph nodes. Chest CT, however, is useful in identifying
bronchial stenosis caused by tuberculosis.4
Effective drug therapy has changed the prognosis of pulmonary
tuberculous disease substantially, but significant stenosis of tra-
cheobronchial involvement can still develop.3 Review of the lit-
erature revealed that no method to date has proved an ideal
treatment for this complication. Although balloon dilation is less
invasive, restenosis of the dilated bronchus occurs frequently. This
study demonstrates the value of staged repeated stenting for man-
agement of long segmental airway obstruction. The tracheostomy
stent has been designed for this purpose and is considered a bridge
stent for this patient group until a suitably sized dynamic Y stent
becomes available. The disadvantages of the metallic stents in-
clude the inability to remove the stents, granuloma formation, stent
migration, fatal massive hemoptysis, rupture of the metallic mesh,
obstruction, and wall perforation. Expandable metallic stents do
Figure 1. Schematic drawing of progressive dilation through the tracheostoma with Bakes common bile duct
dilators and flexible bronchoscope.
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not appear to be a safe and long-term treatment for endobronchial
tuberculosis.5,6 Our strategy requires the development of a stent
device for progressive bouginage and curettage. Design goals
include respiratory support, 3-month tracheostomy stent durability,
and the potential to implant a dynamic Y stent without a necessary
tracheostoma. Tracheostomy stents evolved as a treatment option
in respiratory failure, providing support while offering time for
diseased airways to recover and stabilize. When a tracheostomy
stent is used longer than 3 months, it becomes less complicated and
more cost-effective, making it a convenient treatment for pro-
longed support. A dynamic Y stent device, capable of providing
permanency to patients, could support both acute and chronic
airway stenotic patients. Fundamental to the success of this strat-
egy is the ability to use regular mucolytic agents for extended
periods.
The concept of staged stenting is new, and this approach
through the tracheostoma may be worthy of further investigation,
especially in conditions involving a deteriorated airway. At the
most recent follow-up examination, no local stenosis had occurred.
Thus, staged stenting is an excellent selection for severe long
segmental stenosis and has a low complication rate. Its efficacy
was immediate and durable.
In summary, tuberculous LTBS is locally aggressive and dif-
ficult to treat with a single stent. Repeated dilation and stenting
offers the best chance for clinical improvement. Utilization of
staged stenting appears especially suited for fragile patients when
medical therapy fails.
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Figure 2. A measured length of tracheostomy stent was used to bypass the stenotic areas.
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